SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-19-000002
Filing Date
2019-01-02
Accepted
2019-01-02 09:12:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT AMENDMENT brennerwest-adms123117a2.htm SC 13G/A 100211
  Complete submission text file 0001172661-19-000002.txt   101934
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Subject) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88106 | Film No.: 19500231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 FIFTH AVENUE 41ST FLOOR NEW YORK NY 10110
Business Address 500 FIFTH AVENUE 41ST FLOOR NEW YORK NY 10110 212-801-1255
Brenner West Capital Advisors, LP (Filed by) CIK: 0001425999 (see all company filings)

IRS No.: 202657677 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A